Correlation Between Innate Pharma and Ekinops SA

Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Ekinops SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Ekinops SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Innate Pharma and Ekinops SA, you can compare the effects of market volatilities on Innate Pharma and Ekinops SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Ekinops SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Ekinops SA.

Diversification Opportunities for Innate Pharma and Ekinops SA

0.05

Correlation Coefficient

Innate Pharma  Ekinops SA

Significant diversification

The 3 months correlation between Innate and Ekinops is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Ekinops SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ekinops SA and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Ekinops SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ekinops SA has no effect on the direction of Innate Pharma i.e., Innate Pharma and Ekinops SA go up and down completely randomly.

Pair Corralation between Innate Pharma and Ekinops SA

Assuming the 90 days trading horizon Innate Pharma is expected to generate 0.98 times more return on investment than Ekinops SA. However, Innate Pharma is 1.02 times less risky than Ekinops SA. It trades about 0.0 of its potential returns per unit of risk. Ekinops SA is currently generating about -0.02 per unit of risk. If you would invest  218.00  in Innate Pharma on October 5, 2024 and sell it today you would lose (27.00) from holding Innate Pharma or give up 12.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Innate Pharma  vs.  Ekinops SA

Innate Pharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong technical indicators, Innate Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Ekinops SA

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Ekinops SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Ekinops SA is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Innate Pharma and Ekinops SA

The main advantage of trading using opposite Innate Pharma and Ekinops SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Ekinops SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekinops SA will offset losses from the drop in Ekinops SA's long position.

The idea behind Innate Pharma and Ekinops SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.